The notion of herd immunity is at the center of discussion about global vaccination efforts and the next steps in fighting the Covid-19 epidemic and bringing the economy back on track. In order for the epidemic to stop, the coronavirus has to run out of susceptible hosts to become infected. …
Read More »
LONDON – Eli Lilly said Wednesday that his antibody-based drug has recently shown hospital admissions rates for coronavirus patients diagnosed with mild to moderate symptoms of Covid-19. U.S. The drugmaker said it tested three different doses of LY-Covy 555 against a placebo in a trial registering about 450 patients. A …
Read More »
Reuters Gilead said on Sunday it had agreed to acquire the cancer-drug company Immunomidics for 21 billion. Immunomedic shares rose 106% on Monday following the news. Immunomidics, used to treat various forms of breast cancer, sells Drodelvi and is being evaluated for other possible signs of cancer. Trodelvie was approved …
Read More »
Capped vials of Oxford University’s COVID-19 vaccine candidate, who resumed trials after a break last week. Vincenzo Pinto / Agence France-Presse / Getty Images European stocks rallied on Monday, with US equity futures driven by news of vaccine hope, mergers and acquisitions. Stoxx Europe 600 Index SXXXP, -0.04% The best …
Read More »
The delivery driver, wearing a face mask, rode an electric bicycle on a street in Beijing’s Central Business District on July 16, 2020. Wang Zhao | AFP | Getty Images SINGAPORE – US-China “decoupling” will cost more, but that doesn’t mean Beijing won’t choose to build “mutually exclusive” systems from …
Read More »